Wu Hao, Xu Meihua, Hao Hong, Hill Michael A, Xu Canxia, Liu Zhenguo
Center for Precision Medicine and Division of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia, MO 65212, USA.
Department of Gastroenterology, Third Xiangya Hospital, Central South University, Changsha 410013, China.
J Clin Med. 2022 Jun 2;11(11):3179. doi: 10.3390/jcm11113179.
Population-based studies have suggested that patients with inflammatory bowel disease (IBD) might be at an increased risk for cardiovascular diseases. A meta-analysis was performed on clinical studies to evaluate endothelial function, arterial stiffness, and carotid intima-media thickness (cIMT) in patients with IBD, after searching PubMed, Embase, Cochrane library, and Web of Science databases. A random-effects model was used to allow for the pooling of studies and for determination of the overall effect. After exclusion, a total of 41 eligible studies with 2330 patients with IBD and 2032 matched controls were identified and included for the analysis. It was found that cIMT was significantly increased in patients with IBD as compared with that in matched controls (Cohen's d: 0.63; 95% CI: 0.34, 0.93; I = 91.84%). The carotid-femoral pulse wave velocity was significantly higher in patients with IBD compared to that in matched controls (Cohen's d: 0.76; 95% CI: 0.54, 0.98; I = 70.03%). The augmentation index was also significantly increased in patients with IBD compared to matched control subjects (Cohen's d: 0.35; 95% CI: 0.08, 0.63; I = 61.37%). Brachial artery flow-mediated dilatation was significantly decreased in patients with IBD than that in matched controls (Cohen's d: -0.73; 95% CI: -1.10, -0.36; I = 81.02%). Based on the meta-analysis, it was found that patients with IBD exhibit significant endothelial dysfunction, increased arterial stiffness, and cIMT. Thus, patients with IBD may benefit from aggressive risk stratification for cardiovascular diseases.
基于人群的研究表明,炎症性肠病(IBD)患者患心血管疾病的风险可能会增加。在检索了PubMed、Embase、Cochrane图书馆和Web of Science数据库后,对评估IBD患者内皮功能、动脉僵硬度和颈动脉内膜中层厚度(cIMT)的临床研究进行了荟萃分析。采用随机效应模型进行研究汇总并确定总体效应。排除后,共纳入41项符合条件的研究,其中包括2330例IBD患者和2032例匹配对照进行分析。结果发现,与匹配对照相比,IBD患者的cIMT显著增加(Cohen's d:0.63;95%CI:0.34,0.93;I² = 91.84%)。与匹配对照相比,IBD患者的颈股脉搏波速度显著更高(Cohen's d:0.76;95%CI:0.54,0.98;I² = 70.03%)。与匹配对照相比,IBD患者的增强指数也显著增加(Cohen's d:0.35;95%CI:0.08,0.63;I² = 61.37%)。与匹配对照相比,IBD患者肱动脉血流介导的扩张显著降低(Cohen's d:-0.73;95%CI:-1.10,-0.36;I² = 81.02%)。基于荟萃分析,发现IBD患者存在显著的内皮功能障碍、动脉僵硬度增加和cIMT增加。因此,IBD患者可能受益于积极的心血管疾病风险分层。